簡介

本頁面提供了有關 William Ashton 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示William Ashton已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
Director 1,250
US:SCTL / Societal CDMO, Inc. Director 0
US:SPPI / Spectrum Pharmaceuticals, Inc. Director 0
US:BXRX / Baudax Bio, Inc. Director 42,534
US:GALE / Galena Biopharma, Inc. Director 38,154
US:SCMP / Sucampo Pharmaceuticals, Inc. Director 10,234
如何解讀這些圖表

以下圖表顯示了在William Ashton進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 William Ashton 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2024-12-31 3 MDCX Medicus Pharma Ltd.
Common Shares, no par value ("Common Shares")
1,250
2024-04-08 2024-04-08 4 SCTL Societal CDMO, Inc.
Common Stock
D - Sale to Issuer -73,620 0 -100.00 1.10 -80,982
2024-04-08 2024-04-08 4 SCTL Societal CDMO, Inc.
Common Stock
U - Other -190,002 73,620 -72.07 1.10 -209,002 80,982
2023-08-28 2023-08-28 4 SCTL Societal CDMO, Inc.
Common Stock
P - Purchase 22,222 263,622 9.21 0.46 10,111 119,948
2023-08-01 2023-07-31 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
D - Sale to Issuer -67,660 0 -100.00
2023-05-19 2023-05-17 4 SCTL Societal CDMO, Inc.
Common Stock
A - Award 73,620 241,400 43.88
2022-09-02 2022-08-31 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
A - Award 25,000 67,660 58.60
2022-06-22 2022-06-21 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
S - Sale X -4,283 42,660 -9.12 0.78 -3,362 33,488
2022-06-17 2022-06-15 4 BXRX Baudax Bio, Inc.
Common Stock
A - Award 39,473 42,534 1,289.55
2022-05-20 2022-05-18 4 SCTL Societal CDMO, Inc.
Stock Option (right to buy)
A - Award 118,182 118,182
2022-05-20 2022-05-18 4 SCTL Societal CDMO, Inc.
Common Stock
A - Award 87,500 167,780 108.99
2021-06-22 2021-06-18 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
S - Sale X -9,000 46,943 -16.09 4.24 -38,160 199,038
2021-06-22 2021-06-17 4 SPPI SPECTRUM PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 67,804 67,804
2021-06-22 2021-06-17 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
A - Award 14,277 55,943 34.27
2021-05-17 2021-04-20 4/A REPH Recro Pharma, Inc.
Stock Option (right to buy)
A - Award 38,012 38,012
2021-04-22 2021-04-20 4 REPH Recro Pharma, Inc.
Stock Option (right to buy)
A - Award 38,012 38,012
2021-04-22 2021-04-20 4 REPH Recro Pharma, Inc.
Common Stock
A - Award 26,923 80,280 50.46
2021-04-08 2021-04-07 4 BXRX Baudax Bio, Inc.
Stock Option (right to buy)
A - Award 83,333 83,333
2021-04-08 2021-04-07 4 BXRX Baudax Bio, Inc.
Common Stock
A - Award 56,452 107,185 111.27
2020-06-23 2020-06-22 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
S - Sale X -5,000 41,666 -10.71 3.25 -16,250 135,414
2020-06-23 2020-06-18 4 SPPI SPECTRUM PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 60,000 60,000
2020-06-19 2020-06-18 4 SPPI SPECTRUM PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 60,000 60,000
2020-06-19 2020-06-18 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
A - Award 30,000 46,666 180.01
2020-05-11 2020-05-07 4 REPH Recro Pharma, Inc.
Stock Option (right to buy)
A - Award 12,405 12,405
2020-05-11 2020-05-07 4 REPH Recro Pharma, Inc.
Common Stock
A - Award 8,363 53,357 18.59
2020-05-08 2020-05-06 4 BXRX Baudax Bio, Inc.
Stock Option (right to buy)
A - Award 34,574 34,574
2020-05-08 2020-05-06 4 BXRX Baudax Bio, Inc.
Common Stock
A - Award 22,951 50,733 82.61
2019-12-09 2019-12-05 4 BXRX Baudax Bio, Inc.
Common Stock
A - Award 20,000 27,782 257.00
2019-12-09 2019-12-05 4 REPH Recro Pharma, Inc.
Common Stock
A - Award 17,582 44,994 64.14
2019-06-21 2019-06-20 4 SPPI SPECTRUM PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 20,000 20,000
2019-06-21 2019-06-20 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
A - Award 10,000 16,666 150.02
2019-06-21 2019-06-20 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
S - Sale X -1,667 6,666 -20.00 8.50 -14,170 56,661
2019-06-21 2019-06-19 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
S - Sale X -5,000 8,333 -37.50 8.59 -42,950 71,580
2019-05-10 2019-05-09 4 REPH Recro Pharma, Inc.
Stock Option (right to buy)
A - Award 10,888 10,888
2019-05-10 2019-05-09 4 REPH Recro Pharma, Inc.
Common Stock
A - Award 7,955 27,412 40.89
2018-12-03 2018-11-30 4 SPPI SPECTRUM PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 6,667 6,667
2018-12-03 2018-11-30 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
A - Award 3,333 13,333 33.33
2018-06-19 2018-06-18 4 SPPI SPECTRUM PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 20,000 20,000
2018-06-19 2018-06-18 4 SPPI SPECTRUM PHARMACEUTICALS INC
Common Stock, $0.001 par value
A - Award 10,000 10,000
2018-05-14 2018-05-12 4 REPH Recro Pharma, Inc.
Restricted Stock Units
M - Exercise -13,274 0 -100.00
2018-05-14 2018-05-12 4 REPH Recro Pharma, Inc.
Common Stock
M - Exercise 13,274 19,457 214.69
2018-05-10 2018-05-04 4/A REPH Recro Pharma, Inc.
Stock Option (right to buy)
A - Award 8,965 8,965
2018-05-08 2018-05-04 4 REPH Recro Pharma, Inc.
Stock Option (right to buy)
A - Award 5,742 5,742
2018-05-08 2018-05-04 4 REPH Recro Pharma, Inc.
Common Stock
A - Award 6,183 6,183
2017-10-10 2017-10-10 4 GALE Galena Biopharma, Inc.
Common Stock
A - Award 15,472 38,154 68.21 0.38 5,879 14,499
2017-07-06 2017-07-06 4 GALE Galena Biopharma, Inc.
Common Stock
A - Award 9,866 22,682 76.98 0.59 5,821 13,382
2017-07-06 2017-06-08 4 GALE Galena Biopharma, Inc.
Stock Option (right to buy)
A - Award 5,000 5,000
2017-05-16 2017-05-12 4 REPH Recro Pharma, Inc.
Restricted Stock Units
A - Award 13,274 13,274
2017-04-12 2017-04-10 4 GALE Galena Biopharma, Inc.
Common Stock
A - Award 9,870 12,816 335.03 0.59 5,823 7,561
2017-01-24 2017-01-20 4 GALE Galena Biopharma, Inc.
Common Stock
A - Award 2,946 2,946 1.98 5,833 5,833
2016-07-18 2016-07-14 4 GALE Galena Biopharma, Inc.
Stock Option (right to buy)
A - Award 100,000 100,000
2015-12-18 2015-12-16 4 REPH Recro Pharma, Inc.
Stock Option (right to buy)
A - Award 10,000 10,000
2015-06-23 2015-06-19 4 GALE Galena Biopharma, Inc.
Stock Option (right to buy)
A - Award 100,000 100,000
2015-03-18 2015-03-12 4 SCMP Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -16,666 10,234 -61.96
2015-03-18 2015-03-12 4 SCMP Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -20,000 26,900 -42.64
2015-03-18 2015-03-12 4 SCMP Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -19,096 46,900 -28.94
2015-03-18 2015-03-12 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
S - Sale -16,666 0 -100.00 17.55 -292,488
2015-03-18 2015-03-12 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
M - Exercise 16,666 16,666 6.80 113,329 113,329
2015-03-18 2015-03-12 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
S - Sale -20,000 0 -100.00 17.55 -351,000
2015-03-18 2015-03-12 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
M - Exercise 20,000 20,000 8.62 172,400 172,400
2015-03-18 2015-03-12 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
S - Sale -19,096 0 -100.00 17.55 -335,135
2015-03-18 2015-03-12 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
M - Exercise 19,096 19,096 7.71 147,230 147,230
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -904 65,996 -1.35
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -13,500 66,900 -16.79
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -9,600 80,400 -10.67
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -20,000 90,000 -18.18
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
M - Exercise -30,000 110,000 -21.43
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
S - Sale -904 0 -100.00 17.32 -15,657
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
M - Exercise 904 904 7.71 6,970 6,970
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
S - Sale -13,500 0 -100.00 17.32 -233,820
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
M - Exercise 13,500 13,500 4.41 59,535 59,535
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
S - Sale -9,600 0 -100.00 17.32 -166,272
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
M - Exercise 9,600 9,600 4.41 42,336 42,336
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
S - Sale -20,000 0 -100.00 17.32 -346,400
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
M - Exercise 20,000 20,000 3.56 71,200 71,200
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
S - Sale -30,000 0 -100.00 17.32 -519,600
2015-03-18 2015-03-11 4 SCMP Sucampo Pharmaceuticals, Inc.
Class A Common Stock
M - Exercise 30,000 30,000 4.99 149,700 149,700
2014-12-19 2014-12-17 4 REPH Recro Pharma, Inc.
Stock Option (right to buy)
A - Award 22,000 22,000
2014-06-09 2014-05-09 4 SCMP Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy)
A - Award 20,000 140,000 16.67
2014-03-13 2014-03-12 4 REPH Recro Pharma, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2013-11-27 2013-11-26 4 gale Galena Biopharma, Inc.
Stock Option (right to buy)
A - Award 200,000 200,000
2013-05-30 2013-05-22 4 SCMP Sucampo Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
A - Award 20,000 120,000 20.00
2013-04-30 2013-04-26 4 GALE Galena Biopharma, Inc.
Stock Option (right to buy)
A - Award 100,000 100,000
2012-06-05 2012-05-25 4 SCMP Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to buy)
A - Award 20,000 20,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)